References
- Varga J, Denton CP. Systemic sclerosis and the scleroderma-spectrum disorders. In: Firestein GS, Budd RC, Harris ED Jr, McInnes IB, Ruddy S, Sergent JS, editors. Kelley’s textbook of rheumatology, 8th edn. Philadelphia: W.B. Saunders, 2009;1311–51.
- Hettema ME, Bootsma H, Kallenberg CGM. Macrovascular disease and atherosclerosis in SSc. Rheumatology 2008;47:578–83.
- Mok MY, Chiu SS, Lo Y, Mak HK, Wong WS, Khong PL, Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis. Scand J Rheumatol 2009;38:381–5.
- Botzoris VG, Argyropoulou MI, Voulgari PV, Zikou AK, Drosos AA. Heterotopic ossification in systemic sclerosis. Scand J Rheumatol 2009;38:317–19.
- Wipff J, Dieude P, Avouac J, Tiev K, Hachulla E, Granel B, Association of hypoxia-inducible factor 1A (HIF1A) gene polymorphisms with systemic sclerosis in a French European Caucasian population. Scand J Rheumatol 2009;38:291–4.
- Salmon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 2008;121(Suppl 1);S3–8.
- Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581–90.
- LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202–5.
- Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D’Angelo S, European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001;60:592–8.
- Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999;26:2159–67.
- Chambless LE, Folsom AR, Sharrett AR, Sorlie P, Couper D, Szklo M, Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol 2003;56:880–90.
- Borhani NO, Mercuri M, Borhani PA, Buckalew VM, Canossa-Terris M, Carr AA, Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. J Am Med Assoc 1996;276:785–91.
- Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999;340:115–26.
- Souverein PC, Berard A, Van Staa TP, Cooper C, Egberts AC, Leufkens HG, Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 2004;90:859–65.
- Manenschijn L, van den Akker EL, Lamberts SW, van Rossum EF. Clinical features associated with glucocorticoid receptor polymorphisms. An overview. Ann NY Acad Sci 2009;1179:179–98.